PDCD1 and neoplasm: In addition, these articles underline the fact that the PI3K/AKT, MAPK/ERK, and/or mTOR signaling pathways play a crucial role, via their activation or inhibition, in the pro- or anti-tumor role played by the PD-1 inhibition/blockade.